❌

Normal view

Received before yesterdayNewsfile Cannabis News Releases

Vext Announces Voting Results of Annual General Meeting

11 December 2025 at 17:03
Vancouver, British Columbia--(Newsfile Corp. - December 11, 2025) - Vext Science, Inc.Β (CSE: VEXT) (OTCQX: VEXTF)Β ("VEXT" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, today announced final voting results from its annual general meeting of shareholders held on December 11, 2025 in Vancouver, British Columbia (the "Meeting").The shareholders of the Company voted in favour of all matters included in the management information circular for the...

Herbal Dispatch Unveils Strategic Business Plan for 2026 to Drive Sustainable Growth and Enhance Shareholder Value

11 December 2025 at 03:01
Vancouver, British Columbia--(Newsfile Corp. - December 11, 2025) - Herbal Dispatch Inc. (CSE: HERB) (OTC Pink: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a leading cannabis e-commerce and distribution platform, today announced its comprehensive Strategic Business Plan for 2026. This plan builds on the Company's robust historical performance, aiming to significantly accelerate revenues while improving gross margins and EBITDA.The plan outlines four key priorities designed to expand...

MustGrow Reports Significant U.S. Potato Yield and Economic Performance in Large Scale Field Trials Utilizing TerraSante(TM)

10 December 2025 at 07:00
Mustard-derived organic TerraSanteTM focuses on crop yields, soil and soil microbiome health, and nutrient/water use efficiencies;Large scale field trial showed 2 ton per acre yield increase with larger size potatoes and less culls equating to approximately US$5,000 increase in value per acre; andSignificant soil health benefit when applied in combination with the current grower standard program.Saskatoon, Saskatchewan--(Newsfile Corp. - December 10, 2025) - MustGrow Biologics Corp. (TSXV: MGRO)...

Stock Trend Capital Investment Update and Investments Expansion into Quantum Technology and Mining

9 December 2025 at 06:00
Vancouver, British Columbia--(Newsfile Corp. - December 9, 2025) - Stock Trend Capital Inc. (CSE: PUMP) (FSE: P0G) (OTC Pink: STOCF) (the "Company" or "Stock Trend"), Canada's first publicly traded investment issuer to announce a shareholder dividend policy with a targeted 50% net profit payout ratio to shareholders, is pleased to provide the following update on the Company's investment portfolio, strategic initiative, and outlook. Stock Trend's core mandate remains focused on building...

C21 Investments Announces Renewed Normal Course Issuer Bid

5 December 2025 at 16:00
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2025) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, is pleased to announce that it intends to commence a renewed normal course issuer bid (the "NCIB"), under which it may purchase up to 5,898,596 common shares of the Company ("Common Shares"), representing approximately 5% of the Company's issued and outstanding Common Shares.The Company may purchase Common Shares...

Breadstack and Sticky Cards Unite to Power the Next Generation of Cannabis Retail E-Commerce and Customer Engagement

3 December 2025 at 13:06
Toronto, Ontario--(Newsfile Corp. - December 3, 2025) - Β Breadstack, the fast-growing eCommerce and delivery platform for modern retailers, and Sticky Cards, the leading wallet-based loyalty and customer engagement system, today announced an expanded integration that gives retailers an elegant, end-to-end digital shopping and marketing experience.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10679/276788_141141fb84caf814_001full.jpgThe joint...

City View Green Holdings Inc. Completes Non-Brokered Private Placement

2 December 2025 at 17:43
Toronto, Ontario--(Newsfile Corp. - December 2, 2025) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) (FSE: CVY0) (the "Company" or "City View"), announces that it has closed its non-brokered private placement (the "Offering") previously announced on November 25, 2025. Under the Offering, the Company issued 4,062,500 units at a price of $0.08 per unit for gross proceeds of $325,000. Refer to the November 25, 2025, news release for further information on the Offering. In...

Delota Reports Financial Results for the Three and Six Months Ended September 30, 2025

2 December 2025 at 07:30
Highlights: Total revenue of $8.7 million for the Three Months Ended 2026Total System-Wide Revenue of $10.4 million for the Three Months Ended 2026 31% gross profit margin for the Three Months Ended 2026Total revenue of $18.7 million for the Six Months Ended 2026Total System-Wide Revenue of $21.0 million for the Six Months Ended 202634% gross profit margin for the Six Months Ended 2026Segmented revenue for the Six Months Ended 2026: Vape - B2C: $12.2 million, B2B: $4.5 millionCannabis - B2C:...

Digicann Ventures Appoints New Director to Board

1 December 2025 at 17:00
Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - Digicann Ventures Inc.Β (CSE: DCNN.X)Β ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis industry, is pleased to announce the appointment of Jordan Fogle as a director of the Company. Jordan's appointment as a member of the board of directors (the "Board") is effective today and is subject to all applicable regulatory approvals."We are excited to welcome Jordan to our Board as an...

Red Light Holland Reports Second Quarter 2026 Results and Provides Corporate Update

1 December 2025 at 16:30
Toronto, Ontario--(Newsfile Corp. - December 1, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms, mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal recreational market within the Netherlands, in compliance with all applicable laws, announces its financial and operational results for...

Captiva Verde Announces Brian Conlan as CEO

1 December 2025 at 09:00
Scottsdale, Arizona--(Newsfile Corp. - December 1, 2025) - Captiva Verde Wellness Corp.Β (CSE: PWR)Β (OTC Pink: CPIVF)Β ("Captiva Verde" or the "Company") a public company listed on the Canadian Securities Exchange under the trading symbol PWR and further listed on the US OTC Markets under the symbol CPIVFΒ announces that Brian Conlan has been appointed as the Chief Executive Officer of the company.Brian is the President and co-founder of AHP Strategies, a US government contractor specializing in...

New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions

1 December 2025 at 07:27
Phase II ARCHER trial showed a significant reduction in left ventricular (LV) mass (p=0.0117) and improvements in multiple key cardiac MRI (CMR) measures of structural heart recovery in patients with acute myocarditis.Results provide clinical evidence that CardiolRxβ„’ reduces inflammation-driven structural damage in the heart, an important cause of heart failure progression.The ARCHER data strengthen the scientific and clinical rationale for Cardiol's lead Phase III program in recurrent...

Simply Solventless Announces Q3 2025 Financial and Operating Results, Commercial Improvements, and 91 New Product Listings Across Canada

27 November 2025 at 17:34
Calgary, Alberta--(Newsfile Corp. - November 27, 2025) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC" or "the Company") is pleased to announce its financial and operating results for the three and nine months ended September 30, 2025, including fiscal year to date ("YTD") revenue of $34.5 million and Adjusted EBITDA of $7.5 million, significant commercial team and process improvements, and the receipt of 91 new product listings across Canada either directly or through third parties....

Psyched Wellness Launches Calmer, a 2x Version of Calm and an Enhanced Flavour Profile for Calm

27 November 2025 at 07:30
Toronto, Ontario--(Newsfile Corp. - November 27, 2025) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company specializing in the production and distribution of dietary supplements derived from the Amanita Muscaria mushroom, is pleased to announce the launch of Calmer, a new product offering that delivers twice the potency of its flagship product, Calm.The Company has also enhanced the flavour profile of Calm in both the 30 ml and 60...

PharmaDrug Announces Debt Restructuring

31 October 2025 at 08:58
Toronto, Ontario--(Newsfile Corp. - October 31, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines is pleased to announce that it has agreed to issue $445,686 principal amount of secured convertible debentures to two current holders of the Company's secured convertible debentures that were past their maturity date.Each Debenture will mature on...

PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc

30 October 2025 at 09:00
Toronto, Ontario--(Newsfile Corp. - October 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines is pleased to announce that it has executed a definitive securities exchange agreement (the "Definitive Agreement") with Canurta Limited Partnership ("Canurta") and each of the limited partners of Canurta, the parent entity of Canurta Inc., a...

Herbal Dispatch Brings on Industry Veteran as Strategic Advisor

30 October 2025 at 09:00
Vancouver, British Columbia--(Newsfile Corp. - October 30, 2025) - Herbal Dispatch Inc. (CSE: HERB) (OTC Pink: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a leader in cannabis distribution, is pleased to welcome Jay Wilgar, a 20-year veteran in startup management and business growth, to its team as a Strategic Advisor to the management team.Mr. Wilgar is the former CEO and Chairman of Newstrike Brands Ltd.β€”one of Canada's first licensed cannabis producers, turned industry leader....

Digicann Ventures Agrees to Mutual Termination of Business Combination Agreement with 3Win Corp. and D-3 Merger Sub, Inc.

29 October 2025 at 16:30
Vancouver, British Columbia--(Newsfile Corp. - October 29, 2025) - Digicann Ventures Inc.Β (CSE: DCNN)Β ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis industry, announces that on October 22, 2025 it entered into a Termination, Settlement and Release Agreement (the "Settlement Agreement") with 3Win Corp. ("3Win") and D-3 Merger Sub, Inc. to mutually terminate the Business Combination Agreement dated September 27, 2024, as amended (the "BCA").The...

Flora Growth Corp. Announces Second Purchase of 0G, the Fuel of the 0G Decentralized AI Network

21 October 2025 at 08:00
Fort Lauderdale, Florida--(Newsfile Corp. - October 21, 2025) - Flora Growth Corp. (NASDAQ: FLGC) (the "Company"), which is set to rebrand as ZeroStack, and is the first public company to offer exposure to Decentralized AI through the accumulation of $0G, the native cryptocurrency of the distributed AI infrastructure project 0G ("0G"), today announced the purchase of 880,025 $0G at an average price of $2.27. The purchase represents the Company's second acquisition of $0G since its most recent...

Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027

21 October 2025 at 07:27
MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRxβ„’ in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA.New data from the ARCHER trial, highlighting the magnitude of reduction in left ventricular (LV) mass and the read through to heart failure, to be presented at a cardiology conference in November 2025.Next-generation therapy CRD-38 for heart failure funded through to clinical development, with partnership discussions...
❌